{
    "id": "64040d73201352f04a000010",
    "question": "Can Efgartigimod be used for myasthenia gravis?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, I need to consider the available information about Efgartigimod and its approved uses. Efgartigimod is a medication that is primarily used for the treatment of multiple sclerosis (MS). It is a sphingosine 1-phosphate receptor modulator, which works by reducing inflammation in the central nervous system. However, I couldn't find any information about its use for treating myasthenia gravis, which is an autoimmune disease that affects the nerve-muscle connection and leads to muscle weakness and fatigue. Myasthenia gravis is typically treated with medications such as acetylcholinesterase inhibitors, corticosteroids, and immunosuppressants. Given the different mechanisms of action and the distinct pathophysiology of these two conditions, it is unlikely that Efgartigimod would be used for treating myasthenia gravis. Therefore, based on the available information, the answer is unlikely to be A. yes.\", \"answer_choice\": \"B\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 29.30608057975769
}